Bristol-Myers Squibb Pipeline

Clinical trials and expected approvals

Pro Feature

Get full access to pipeline analysis, trial details, and approval forecasts.

-

Active Trials

-

Phase 3

-

Phase 2

-

Phase 1

-

Results Pending

📊

Pipeline Summary

FDA Decision 1 upcoming PDUFA date

Iberdomide + daratumumab/dexamethasone Relapsed or refractory multiple myeloma NDA

Aug 17, 2026 83 days Calendar →

Loading...

Therapeutic Areas

Drug Targets

Companies

Explore

Indication mapping uses a manual taxonomy — see methodology and coverage there.